Autopsy report · NCT05127811

A Phase I Study of ZN-d5 in Chinese Subjects With Non-Hodgkin Lymphoma

“Sponsor's decision”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 1 year 7 months before it stopped.
• 8 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 1

Sponsor

Zentera Therapeutics HK Limited

Sponsor type

Industry

Conditions

Non-Hodgkin Lymphoma

Interventions

ZN-d5

Participants

8

Sites

3

Countries

China

Trials that died the same way

• Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
  “Sponsor decision” (98% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.